New Delhi: The International Gemmological Institute (IGI) IPO allotment can be checked on BSE website – and Kfin Technologies website – The initial public offer was open for subscription between December 15-17, 2024.
International Gemmological Institute (IGI) IPO GMP today signalled a listing gains of around 28 per cent. According to investorgain, the IGI GMP today was recorded at Rs 116. With the price band of Rs 417, the shares are expected tp make their debut at Rs 533 apiece, indicating a gain of 27.82 per cent.
IGI IPO allotment status check on BSE
- Visit
- In the ‘Issue Type’ section – Select ‘Equity’ and click on International Gemological Institute (India) IPO
- Submit PAN or application number
- Click the ‘Submit’ button
Check IGI IPO allotment status on Kfin Technologies website
- Visit
- From the dropdown menu, select International Gemmological Institute India
- Enter application number, PAN or demat account number
- Next step is to verify the Captcha
- Click on Submit to view IPO allotment status
IGI IPO subscription status, listing date
The IGI IPO received a tremendous response from the investors as the bidding was done for shares of 1,9786,25,565 against the offered shares of 5,85,60,902. The International Gemmological Institute IPO received an overall subscription of 33.78 times. The Qualified Institutional Buyers (QIB) portion fetched 45.80 times subscription. The Non-Institutional Investors (NII) category closed with 24.84 times subscription, while the Retail Investors quota recorded 11.21 times subscription.
The IGI share will list on BSE and NSE with a tentative date December 20, 2024. The International Gemmological IPO price band was set in the range of Rs 397 to Rs 417 per share. Book Running managers included Morgan Stanley India Company Pvt Ltd, SBI Capital Markets Limited, Axis Capital Limited, and Kotak Mahindra Capital Company Limited. Kfin Technologies Limited is the registrar for the issue.
(Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO and Mutual Funds.)
Comments are closed.